Multiplex Mass Spec Assay for Small-molecule Inhibitors of CD73 with Diverse Modalities
Medicine, Health Care Multiplex Mass Spec Assay for…
Published: January 17, 2018.
Released by SLAS (Society for Laboratory Automation and Screening)
A new original research article in SLAS Discovery presents a fast, sensitive, and robust methodology for screening small molecule inhibitors against CD73/Ecto-5′-Nucleotidase, a promising target for developing anti-cancer drugs.
The methodology described by authors Gejing Deng (Sanofi) et al., uses multiple stable isotope-labeled substrates for carrying out CD73 reactions followed by sample pooling then simultaneously quantifying multiple reaction products using ultra-fast RapidFire-MS/MS.
In contrast to other optical based methodologies, this methodology allows identifying molecules with diverse inhibition modalities and characterizing inhibitors using both recombinant CD73 and CD73+ cells.
Chinese French German Italian Japanese Korean Portuguese Russian Spanish